e-learning
resources
Milan 2017
Wednesday, 13.09.2017
Novel imaging findings characterising various lung diseases and their prognoses
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparison of in-vivo lung morphometry models from multiple b-value diffusion-weighted MRI in healthy controls, IPF and COPD patients
H. Chan (Sheffield, United Kingdom)
Source:
International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses
Session:
Novel imaging findings characterising various lung diseases and their prognoses
Session type:
Oral Presentation
Number:
4644
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Chan (Sheffield, United Kingdom). Comparison of in-vivo lung morphometry models from multiple b-value diffusion-weighted MRI in healthy controls, IPF and COPD patients. 4644
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Quantitative multivolume proton-magnetic resonance imaging in patients with cystic fibrosis lung disease: comparison with clinical indicators
Source: Eur Respir J, 53 (5) 1702020; 10.1183/13993003.02020-2017
Year: 2019
Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial
Source: Eur Respir J 2009; 34: 1311-1321
Year: 2009
Comparison of 1H MRI and 3He MRI ventilation images in patients with cystic fibrosis and patients with lung cancer
Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Year: 2018
MRI of delayed-ventilation perfusion matching in COPD
Source: Annual Congress 2012 - Functional imaging of the lung parenchyma, tumours and circulation
Year: 2012
Comparison of the thoracic CT-based computational model with hyperpolarized Xenon-129 MRI and SPECT images to assess pulmonary ventilation in COPD patients
Source: International Congress 2019 – Imaging: new insights that pulmonologists should be aware of
Year: 2019
Gas-exchange and ventilation imaging of COPD in comparison to a healthy cohort using hyperpolarized Xenon-129 MRI
Source: International Congress 2019 – Imaging of airway diseases
Year: 2019
Regional hyperpolarised 129-xenon diffusion-weighted MRI in patients with IPF
Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease
Year: 2020
MRI and CT imaging of in vivo models of drug-induced interstitial lung diseases.
Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease
Year: 2018
Comparison of dynamic contrast-enhanced MRI tracer-kinetic modeling in the lung of smokers v non-smokers
Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging
Year: 2012
Multivolume magnetic resonance imaging (1H-MRI) for the longitudinal assessment of cystic fibrosis (CF) lung disease: comparison with spirometry
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020
Assessment of chest magnetic resonance imaging in non-cystic fibrosis chronic lung disease: comparison to high-resolution computed tomography and correlation with clinical and pulmonary function data
Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease
Year: 2009
Hyperpolarised 129-xenon diffusion-weighted MRI in interstitial lung disease
Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019
Year: 2019
Functional evaluation of emphysema using diffusion-weighted
3
helium-MRI, HRCT and lung function tests
Source: Eur Respir J 2003; 22: Suppl. 45, 532s
Year: 2003
Ventilation heterogeneity assessed in patients with mild cystic fibrosis and asthma using Hyperpolarised gas MRI histogram analysis
Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses
Year: 2017
3D PREFUL: Novel high resolution dynamic lung ventilation imaging in patients with asthma, cystic fibrosis and COPD and healthy volunteers
Source: Virtual Congress 2020 – Imaging-based phenotyping in pulmonary disease
Year: 2020
Assessment of a new magnetic resonance imaging (MRI)-scoring- system for pulmonary changes in patients with cystic fibrosis (CF) – comparison with clinical parameters and high resolution computed tomography (HRCT)
Source: Annual Congress 2006 - New modalities and application in imaging of the chest
Year: 2006
Helium-3 MRI diffusion coefficient: correlation to morphometry in a model of mild emphysema
Source: Eur Respir J 2003; 22: 14-19
Year: 2003
Magnetic resonance imaging (MRI) as a non-invasive, radiation-free imaging modality to study the onset and progression of lung disease in infants and young children with cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: detection and monitoring of early lung disease
Year: 2011
Quantitative multivolume magnetic resonance imaging (1H-MRI) in patients with cystic fibrosis (CF) lung disease:comparison with FEV1 and lung clearance index (LCI)
Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers
Year: 2017
Longitudinal monitoring of lung microstructure with HP gas diffusion-weighted MRI in mild cystic fibrosis children
Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept